Phenotyping cardiogenic shock E Zweck, KL Thayer, OKL Helgestad, M Kanwar, M Ayouty, AR Garan, ... Journal of the American Heart Association 10 (14), e020085, 2021 | 104 | 2021 |
Temporal trends in incidence and patient characteristics in cardiogenic shock following acute myocardial infarction from 2010 to 2017: a Danish cohort study OKL Helgestad, J Josiassen, C Hassager, LO Jensen, L Holmvang, ... European journal of heart failure 21 (11), 1370-1378, 2019 | 99 | 2019 |
Contemporary trends in use of mechanical circulatory support in patients with acute MI and cardiogenic shock OKL Helgestad, J Josiassen, C Hassager, LO Jensen, L Holmvang, ... Open Heart 7 (1), e001214, 2020 | 81 | 2020 |
Risk factors of late cardiogenic shock and mortality in ST-segment elevation myocardial infarction patients L Obling, M Frydland, R Hansen, OK Møller-Helgestad, MG Lindholm, ... European heart journal: acute cardiovascular care 7 (1), 7-15, 2018 | 62 | 2018 |
Single-centre experience with the Impella CP, 5.0 and RP in 109 consecutive patients with profound cardiogenic shock PB Jensen, SH Kann, KT Veien, OK Møller-Helgestad, JS Dahl, CS Rud, ... European Heart Journal: Acute Cardiovascular Care 7 (1), 53-61, 2018 | 55 | 2018 |
Lactate is a prognostic factor in patients admitted with suspected ST-elevation myocardial infarction M Frydland, JE Møller, S Wiberg, MG Lindholm, R Hansen, ... Shock 51 (3), 321-327, 2019 | 38 | 2019 |
Impella CP or VA-ECMO in profound cardiogenic shock: left ventricular unloading and organ perfusion in a large animal model OK Moller-Helgestad, JA Hyldebrandt, A Banke, CS Rud, NLJ Udesen, ... EuroIntervention 14 (15), e1585-e1e92, 2019 | 32 | 2019 |
Impact of concomitant vasoactive treatment and mechanical left ventricular unloading in a porcine model of profound cardiogenic shock NLJ Udesen, OKL Helgestad, ABS Banke, PH Frederiksen, J Josiassen, ... Critical Care 24, 1-10, 2020 | 23 | 2020 |
Proteomic discovery and validation of the confounding effect of heparin administration on the analysis of candidate cardiovascular biomarkers HC Beck, LO Jensen, C Gils, AMM Ilondo, M Frydland, C Hassager, ... Clinical Chemistry 64 (10), 1474-1484, 2018 | 21 | 2018 |
Biomarkers predictive of late cardiogenic shock development in patients with suspected ST-elevation myocardial infarction M Frydland, JE Møller, MG Lindholm, R Hansen, S Wiberg, ... European Heart Journal: Acute Cardiovascular Care 9 (6), 557-566, 2020 | 20 | 2020 |
Hemodynamic and metabolic recovery in acute myocardial infarction-related cardiogenic shock is more rapid among patients presenting with out-of-hospital cardiac arrest J Josiassen, OK Lerche Helgestad, JE Møller, J Kjaergaard, ... PLoS One 15 (12), e0244294, 2020 | 18 | 2020 |
The association of diabetes and admission blood glucose with 30-day mortality in patients with acute myocardial infarction complicated by cardiogenic shock M Thoegersen, J Josiassen, OKL Helgestad, H Berg Ravn, H Schmidt, ... European Heart Journal: Acute Cardiovascular Care 9 (6), 626-635, 2020 | 18 | 2020 |
Large porcine model of profound acute ischemic cardiogenic shock OK Møller-Helgestad, HB Ravn, JE Møller Experimental Models of Cardiovascular Diseases: Methods and Protocols, 343-352, 2018 | 18 | 2018 |
Cardiogenic shock due to predominantly right ventricular failure complicating acute myocardial infarction J Josiassen, OKL Helgestad, JE Møller, H Schmidt, LO Jensen, ... European heart journal. Acute cardiovascular care 10 (1), 33-39, 2021 | 17 | 2021 |
Support with intra-aortic balloon pump vs. Impella2. 5® and blood flow to the heart, brain and kidneys—An experimental porcine model of ischaemic heart failure OK Møller-Helgestad, CB Poulsen, EH Christiansen, JF Lassen, HB Ravn International Journal of Cardiology 178, 153-158, 2015 | 14 | 2015 |
Unloading using Impella CP during profound cardiogenic shock caused by left ventricular failure in a large animal model: impact on the right ventricle J Josiassen, OKL Helgestad, NLJ Udesen, A Banke, PH Frederiksen, ... Intensive Care Medicine Experimental 8, 1-11, 2020 | 13 | 2020 |
Admission leukocyte count is associated with late cardiogenic shock development and all-cause 30-day mortality in patients with st-elevation myocardial infarction A Klein, S Wiberg, C Hassager, M Winther-Jensen, R Frikke-Schmidt, ... Shock 53 (3), 299-306, 2020 | 13 | 2020 |
Prognostic importance of culprit lesion location in cardiogenic shock due to myocardial infarction J Josiassen, OKL Helgestad, JE Møller, L Holmvang, LO Jensen, ... European heart journal. Acute cardiovascular care 10 (1), 25-32, 2021 | 11 | 2021 |
Timing and causes of death in acute myocardial infarction complicated by cardiogenic shock (from the RETROSHOCK cohort) LW Davodian, JKP Larsen, AL Povlsen, J Josiassen, OKL Helgestad, ... The American journal of cardiology 171, 15-22, 2022 | 9 | 2022 |
Neutrophil gelatinase-associated lipocalin (NGAL) measured at admission is associated with development of late cardiogenic shock and mortality in patients with ST-segment … M Frydland, R Møgelvang, JE Møller, OKL Helgestad, L Holmvang, ... Shock 56 (2), 255-259, 2021 | 9 | 2021 |